May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Corneal Cells Release IL–6 When Treated With Immune Complex (HSV–1–Human IgG) or Transfected With HSV–DNA
Author Affiliations & Notes
  • K. Hayashi
    Immunology/Virology Section Lab. Immunology, National Eye Institute, Bethesda, MD
  • L.C. Hooper
    Immunology/Virology Section Lab. Immunology, National Eye Institute, Bethesda, MD
  • M.S. Chin
    Immunology/Virology Section Lab. Immunology, National Eye Institute, Bethesda, MD
  • C.N. Nagineni
    Immunology/Virology Section Lab. Immunology, National Eye Institute, Bethesda, MD
  • B. Detrick
    Department of Pathology, Johns Hopkins University, Baltimore, MD
  • J.J. Hooks
    Immunology/Virology Section Lab. Immunology, National Eye Institute, Bethesda, MD
  • Footnotes
    Commercial Relationships  K. Hayashi, None; L.C. Hooper, None; M.S. Chin, None; C.N. Nagineni, None; B. Detrick, None; J.J. Hooks, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3068. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Hayashi, L.C. Hooper, M.S. Chin, C.N. Nagineni, B. Detrick, J.J. Hooks; Corneal Cells Release IL–6 When Treated With Immune Complex (HSV–1–Human IgG) or Transfected With HSV–DNA . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3068.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study IL–6 secretion and TLR–3 and –9 gene expression in corneal cells with HSV DNA transfection and HSV–anti–HSV IgG immune complex (IC) treatment

Methods: : Human corneal epithelial cells (HCE) and primary human corneal fibroblasts (HCRF) were transfected with HSV DNA or treated with IC. Gene expression of TLR–3 and –9 in these cells were quantitated by real time PCR. Supernatants were assayed for IL–6 by ELISA. HCRF transfected with HSV DNA were treated with the following reagents:TLR–9 inhibitory oligomer(iODN:TTAGGG) or PI3–kinase inhibitor (LY294002). To the selected monolayers treated with iODN, anti–TLR–3 antibody was added. After 24 hours, supernatants were assayed for IL–6.

Results: : When HCE and HCRF were transfected with HSV DNA or treated with IC, TLR–3 and –9 gene expression were augumented. Transfected or IC treated HCRF released greater amount of IL–6 than HCE. Maximum IL–6 release was obtained when HCRF were transfected with HSV–1 McKrae or MP strain DNA or treated with IC. Treatment of HCRF transfected with McKrae DNA with iODN, inhibited IL–6 release dose dependently. When anti–TLR–3 antibody was combined with iODN, inhibition of IL–6 release enhanced and reached 80%. Further inhibition of IL–6 release was obtained using PI3–kinase inhibitor. These results indicated that IL–6 release from HCRF is at least in part mediated by TLR–3 and –9.

Conclusions: : HSV DNA and IC enhanced IL–6 release from corneal fibroblasts. These phenomena were mediated via augumented TLR–3 and –9 gene expression.

Keywords: herpes simplex virus • keratitis • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×